36 research outputs found

    Additional file 1: Table S1. of Bat rabies surveillance in France: first report of unusual mortality among serotine bats

    No full text
    Results of passive bat rabies surveillance undertaken in Moselle and Meurthe & Moselle. Results are detailed by department, date, city of isolation and species of bats. (DOCX 23 kb

    Bat rabies in France.

    No full text
    <p>Negative case: black dot, positive case: red triangle (A). Distribution of all the bat samples analysed for rabies diagnosis; A1)1989–2000; A2) 2001–2013 (B). Location of serotine (<i>Eptesicus serotinus</i>) samples analysed for rabies diagnosis; B1)1989–2000; B2)2001–2013.</p

    Rabies occurrence rate detected in serotine bats in France from 1989–2013 in the frame of the bat rabies surveillance network and according different environmental factors: season (a), year (b), regional cluster (c) and sex (d).

    No full text
    <p>Rabies occurrence rate detected in serotine bats in France from 1989–2013 in the frame of the bat rabies surveillance network and according different environmental factors: season (a), year (b), regional cluster (c) and sex (d).</p

    Regional clusters with geographical location of the 47 EBLV-1 a and b samples according to the results of the phylogenetic N gene analysis.

    No full text
    <p>Samples were located geographically according to the defined lineage: [B1 (north-west), B2 (centre), B3 (north -east)] and A (south-west)]. The numbers correspond to the identification numbers of isolates</p

    Neigbour-Joining and Bayesian Phylogenetics.

    No full text
    <p>A. NJ phylogenetic tree comparing partial N gene sequence from 32 French EBLV-1 isolates from 1989–2012, 11 referenced European EBLV-1 strains (Poland, Holland, Luxembourg, Spain, Denmark, Germany, Russia), 1 EBLV-1 isolate from Luxembourg, 5 EBLV-2 strains (Finland, Germany, United Kingdom, Switzerland, Holland) and two BBLV isolates (France, Germany). Relationships are presented as a rooted phylogram with WCBV (EF614258). Bootstraps above 70% are significant.</p

    Overview of the cost of OV in Estonia, Latvia and Lithuania from 2006 to 2011.

    No full text
    a<p>: between (y) and (y−1).</p>b<p>: 1 OV campaign.</p>c<p>: 75% of EC funding.</p>d<p>: It is assumed that the effect of OV is observable at year y+1. This ratio corresponds to the EC funding from 2006 to 2009/newly uninfected area from 2007 to 2010.</p><p>(M): Mean value.</p><p>This table shows the number of baits used, the funding allocated for rabies prevention by the European Commission (EC) “approving annual and multi-annual programmes and the financial contribution”, the area vaccinated, the uninfected and newly uninfected areas and the type of vaccine used. Different ratios were calculated : Number of baits distributed from 2006–2011 per country per vaccinated area in km<sup>2</sup>. EC funding over the 2006–2010 period/newly uninfected areas in the country in km<sup>2</sup>.</p
    corecore